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Evaluation of a Computer-Aided Diagnosis System for
Diabetic Retinopathy Screening on Public Data
Clara I. Sa´nchez,1 Meindert Niemeijer,2,3 Alina V. Dumitrescu,4
Maria S. A. Suttorp-Schulten,5 Michael D. Abra`moff,3,4 and Bram van Ginneken1
PURPOSE. To evaluate the performance of a comprehensive
computer-aided diagnosis (CAD) system for diabetic retinopa-
thy (DR) screening, using a publicly available database of reti-
nal images, and to compare its performance with that of hu-
man experts.
METHODS. A previously developed, comprehensive DR CAD
system was applied to 1200 digital color fundus photographs
(nonmydriatic camera, single field) of 1200 eyes in the publicly
available Messidor dataset (Methods to Evaluate Segmentation
and Indexing Techniques in the Field of Retinal Ophthalmol-
ogy (http://messidor.crihan.fr). The ability of the system to
distinguish normal images from those with DR was determined
by using receiver operator characteristic (ROC) analysis. Two
experts also determined the presence of DR in each of the
images.
RESULTS. The system achieved an area under the ROC curve of
0.876 for successfully distinguishing normal images from those
with DR with a sensitivity of 92.2% at a specificity of 50%.
These compare favorably with the two experts, who achieved
sensitivities of 94.5% and 91.2% at a specificity of 50%.
CONCLUSIONS. This study shows, for the first time, the perfor-
mance of a comprehensive DR screening system on an inde-
pendent, publicly available dataset. The performance of the
system on this dataset is comparable with that of human
experts. (Invest Ophthalmol Vis Sci. 2011;52:4866–4871)
DOI:10.1167/iovs.10-6633
Diabetic retinopathy (DR) is the most common cause ofblindness in the working population of the United States
and Europe. DR will become a more important problem world-
wide. The World Health Organization (WHO) predicts that
the number of patients with diabetes will increase to 366
million in 2030.1 In patients with diabetes, early diagnosis
and treatment have been shown to prevent visual loss and
blindness.2–4 However, more than 50% of the diabetes pop-
ulation worldwide does not undergo any form of eye exam-
ination.5 The use of digital photography of the retina exam-
ined by expert readers during screening programs has been
shown to be both sensitive and specific in the detection of
the early signs of diabetic retinopathy.6,7 Access to screen-
ing services is an increasingly important and pressing issue,
especially given the increasing prevalence of diabetes. To
increase access to screening, several groups have proposed
the use of automated computer systems for determining
what screened patients should be seen by an ophthalmolo-
gist and what patients can safely return for screening 1 year
later.5,8,9 These types of automated systems have the poten-
tial to reduce the workload for screening ophthalmologists
while maintaining a high sensitivity (i.e., above 90%) for the
detection of patients with DR.
For automated systems to be applied in clinical practice,
they should be evaluated extensively and thoroughly. One of
the goals of this evaluation is to show that automated sys-
tems can detect DR with a sensitivity comparable to that of
a human expert while maintaining a high enough specificity
to attain the needed reduction in the ophthalmologist’s
workload. In addition, evaluation of systems should be per-
formed on independent and, preferably, publicly available
data so that different groups can compare the performance
of their automated systems on the same set of data. Of
additional importance, the performance record of several
expert observers on this same dataset should also be avail-
able to facilitate the comparison between automated sys-
tems and humans.
Currently, two large studies (i.e., involving more than
10,000 examinations) by two research groups have been pub-
lished.5,8 These studies used datasets that the authors expected
to be typical of the populations on which their proposed
systems would be used. Although internally valid, this ap-
proach does not allow external validity (on other populations
and datasets) to be determined. Recent work on discriminating
between normal and pathologic retinal images10 has been
evaluated with a small subset from a public database. Many
more groups have evaluated components of DR screening
systems on smaller datasets.11 Recently, more public data for
the evaluation of algorithms have become available.12–14 The
largest publicly available dataset is Messidor, consisting of 1200
macula-centered digital fundus photographs (http://messidor.
crihan.fr.).14 Although this dataset was obtained in a clinical
setting and thus with a distribution of diabetic retinopathy
disease severity different from a screening population, it has
the advantage of increased external validity, because this dis-
tribution is wider, in addition to its public availability.
The purpose of the present study was to apply our compre-
hensive automated DR screening system to the Messidor data-
set and compare its performance with that of two human
experts.
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METHODS
Data
The Messidor database14 was established to facilitate studies on com-
puter-aided diagnosis of DR. The database consists of 1200 color
fundus images of the posterior pole. The included patients were
randomly chosen among the diabetic patients from the ophthalmology
departments involved in the Messidor project.14 An example of an
image from the Messidor database is shown in Figure 1a. The images
were acquired in three different ophthalmology departments, 400
images in each department, using a nonmydriatic digital retinal camera
(TRC NW5; TopCon, Tokyo, Japan) with 45° field of view. Eight
hundred images were acquired with pupil dilation (one drop of tropi-
camide at 0.5%) and 400 images without dilation. Image sizes were
1440  960 in 588 images, 2240  1488 in 400 images, and 2304 
1536 in 212 images. All the images were saved in uncompressed TIFF
format.
For each image, two diagnoses, retinopathy grade, and risk of
macular edema, have been provided with the dataset. These diagnoses
were obtained by medical experts according to the grading schemes
shown in Table 1 (Erginay A, et al. IOVS 2008;49:ARVO E-Abstract
2137). The diagnoses were considered to be the reference standard for
the performance analysis in our work. According to the reference
standard, a total of 546 images were classified as normal and 654 as
presenting signs of DR, specifically 153 with retinopathy grade 1, 247
with retinopathy grade 2, and 254 with retinopathy grade 3. In addi-
tion, 974 images do not show risk of macular edema; whereas 75 and
151 images presented risk grades 1 and 2 for macular edema, respec-
tively. Information about patients was removed to ensure patient
privacy.
Computer-Aided Diagnosis System for Diabetic
Retinopathy Screening
The proposed computer-aided diagnosis (CAD) system analyzes a pa-
tient’s examination to identify lesions associated with DR and assigns
FIGURE 1. Examples of the outputs
of the proposed CAD system. (a)
Original image from the Messidor da-
tabase (filename: 20051020 57566
0100 PP.tif), kindly provided by the
Messidor program partners (http://
messidor.crihan.fr/download-en.
php). The quality-verification module
automatically assigned a probability
of 0.98 that the image would have
good quality. (b) Output of the auto-
matic vessel segmentation module.
The image shows the obtained pixel
probability map indicating the likeli-
hood of the pixel to belong to a ves-
sel. White: higher probability. (c)
Output of the automatic optic disc
detection module. Blue spot: the ob-
tained location within the image
with the highest probability of being
the optic disc center. (d) Outputs of
the automatic red and bright lesion-
detection modules. Each candidate is
assigned a value indicating the prob-
ability of being a true lesion. The
color scales represent the range of
values for the red and bright lesion
probability.




0* (A  0) and (H  0)
1 (0  A  5) and (H  0)
2 [(5  A  15) and (0  H  5)] and
(NV  0)
3 (A  15) or (H  5) OR (NV  0)
Risk of macular edema
0* No visible hard exudates
1 Shortest distance between macula and hard
exudates  one papilla diameter
2 Shortest distance between macula and hard
exudates  one papilla diameter
A, microaneurysms; H, hemorrhages; NV, neovascularization.
* Normal.
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each examination a probability between 0 and 1, with 1 indicating that
the examination should be referred to an ophthalmologist. A patient is
deemed referable if the examination contains DR lesions or the exam-
ination is ungradable due to low quality. To accomplish this, the
proposed system consists of various modules responsible for the fol-
lowing tasks (shown in Fig. 1).
Preprocessing. Before finding anatomic landmarks and lesions
within the image, its field of view (FOV) is detected by finding the
optimal FOV template among a predefined group of templates that
match the image. The image is then resized to have an FOV with a
standardized diameter of 650 pixels independent of the image resolu-
tion.15
Quality Verification. This module determines the quality level
of the image. The technique relies on the assumption that an image of
sufficient quality should contain particular image structures—namely,
the vasculature, the optic disc (OD), and the background, according to
a certain predefined distribution. A compact representation of the
image structures is obtained applying a Gaussian filter bank (GFB) to
the image and clustering the outputs. One cluster represents one
structure. The distribution of the image structures within the image is
then represented by means of a histogram with one bin per cluster.
Using this histogram together with histograms of the R, G, and B color
planes as features, a support vector machine is trained to assess the
image quality. The output of this module is a probability per image
indicating the likelihood the quality of the image is normal. It should be
noted that the output of this module is not used to discard images of
low quality, only to analyze the quality level.16
Vessel Segmentation. The vasculature is one of the most
important anatomic structures in retinal images. Vessel segmentation is
necessary to distinguish small vessels from red lesions and as an aid for
the identification of other anatomic landmarks, such as the OD. A pixel
probability map indicating the likelihood that the pixel belongs to a
FIGURE 2. Fitted ROC curves for the human experts and the CAD system: (a) Normal and abnormal ROC curves; (b) Normal/grade 1 ROC curve;
(c) normal/grade 2 ROC curve; and (d) normal/grade 3 ROC curve.
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vessel is obtained as output by means of pixel classification using GFB
features and a supervised classifier.17
OD Detection. The OD is another important anatomic structure.
The identification of this element is necessary to prevent erroneously
detected bright lesions within the OD. The OD is identified calculating
a regression rule between its center location and a group of features
based on intensity, vessel orientation, and density. The output of the
module is a location within the image with the highest probability that
it is the OD center.18
Red Lesion Detection. Red lesions, comprising microaneu-
rysms, hemorrhages, and vascular abnormalities, are important signs of
DR and their detection is therefore of paramount importance for a DR
screening system. Potential red lesion locations are identified by using
a hybrid approach based on mathematical morphology, specifically
designed for smaller candidates, and a supervised pixel classification
using GFB features, for the detection of larger red lesions. The detected
candidates are then assigned a probability of being a true red lesion,
using a supervised classifier and a group of features describing the
candidate shape, structure, color, and contrast.19
Bright Lesion Detection. Bright lesions, such as exudates,
cotton wool spots, or drusen, are frequently encountered in a DR
population screening. Only the first two are associated with DR.
Similar to red lesion detection, a supervised pixel classification is first
performed to obtain candidates that may be bright lesions. A probabil-
ity that each candidate is a true bright lesion is then obtained by means
of supervised classification using a group of candidate features, such as
shape, contrast, color, and distance to the nearest red lesion.20
The outputs of the different modules must be combined to obtain
a final decision about the patient’s examination. To accomplish that, a
group of features based on the diverse outputs of the aforementioned
modules are calculated, such as the quality likelihood or the highest
likelihood of red or bright lesions in the examination. These features
are given as input to a k nearest-neighbor (kNN) classifier. This classi-
fier was trained on an independent training set not used for any other
purpose in this research. The output of this classifier is a per-exami-
nation probability indicating the likelihood that the examination would
be referred to an ophthalmologist.15
Observer Study
To compare the performance of the CAD system with that of experts,
a general ophthalmologist and a retinal specialist, with 4 and 20 years
of DR screening experience, respectively, manually analyzed the im-
ages in the Messidor database. Both experts have experience with
digital and real-time examinations. The specialists were asked to pro-
vide a value between 0 and 100 for each image, indicating the proba-
bility of the presence of DR in the image. In addition, the specialists
evaluated the retinopathy grade and the risk of macular edema, accord-
ing to the grading scheme shown in Table 1. The images were revised
in different sessions depending on the readers’ availability. The resam-
pling images were displayed in a LCD screen without any calibration
and with the ability to zoom and pan.
Data Analysis
The performances of the CAD and the two experts were compared
separately with the reference standard. For this purpose, ROCKIT
software21 was used to analyze the outcomes of the CAD and the
experts. Using the raw output data as input, the software applied a
maximum-likelihood estimation to fit a binormal receiver operating
characteristic (ROC) curve.22 The area under the ROC curve, Az, was
used as a measure of the system or human performance, and a univar-
iate z-score test was performed to compare the performance of the
CAD system and the experts. Overall agreement between the special-
ists and the reference standard was calculated using weighted  statis-
tics (SPSS, ver. 17.0.0; SPSS, Chicago, IL).
We performed four experiments for both the CAD system and the
experts, obtaining four ROC curves:
● Normal/abnormal ROC curve: All the images in the MESSIDOR
database were used.
● Normal/grade 1 ROC curve: Only normal images and images with
retinopathy grade 1 according to the reference standard were used.
● Normal/grade 2 ROC curve: Only normal images and images with
retinopathy grade 2 according to the reference standard were used.
● Normal/grade 3 ROC curve: Only normal images and images with
retinopathy grade 3 according to the reference standard were used.
These experiments allowed an analysis of the performance for the
different retinopathy grades separately.
RESULTS
Human Experts’ Performance
The fitted ROC curves for both experts are shown in Figure 2.
The areas under the different ROC curves are summarized in
Tables 2 to 6 show the contingency tables and the weighted 
agreement between the expert and the reference standard for
the assessment of retinopathy grade and risk of macular edema.
CAD System Performance
The fitted ROC curves for the CAD system are shown in Figure
2. The corresponding areas under the different curves are
summarized in Table 2. Setting the operating point at 50%
specificity on the normal or abnormal ROC curve, a sensitivity
of 92.2% was obtained, with a total of 51 abnormal images
wrongly classified as normal. The CAD system misclassified 29
images with retinopathy grade 1, 19 with grade 2, and 3 with
grade 3, according to the reference standard. Among the 19
misclassified images with grade 2, the experts agreed on only
two images as abnormal and both graded seven images as
normal. The three misclassified images with grade 3 presented
large hemorrhages. Specialist A assessed them as grade 1 or 2
but not grade 3, and specialist B classified two of them as
normal. None of the 51 misclassified images presented a risk of
TABLE 2. The Az under the ROC Curve and the 95% Confidence Interval (CI), as a Measure of the
Performance of the Two Experts and the CAD System
Expert A Expert B CAD System
Az 95% CI Az 95% CI Az 95% CI
Normal/abnormal 0.922 0.902–0.936 0.865 0.789–0.925 0.876* 0.856–0.895
Normal/grade 1 0.789 0.728–0.841 0.623 0.258–0.899 0.721*† 0.673–0.765
Normal/grade 2 0.940 0.971–0.958 0.904 0.839–0.948 0.867* 0.836–0.893
Normal/grade 3 0.992 0.986–0.996 0.981 0.969–0.989 0.973* 0.961–0.982
Az, area under the ROC curve.
*† CAD system performance is nonsignificantly different (P  0.05) compared with the experts B and
A, respectively.
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macular edema with grade 2. At a specificity of 50%, the
experts A and B obtained a sensitivity of 94.5% and 91.2%,
respectively, and 77.5% and 87.8% of the images showed a
probability higher than 0.95 and 0.8 of having a normal quality,
respectively.
DISCUSSION
In this article, a CAD system was evaluated with independent
and publicly available data. This kind of evaluation is of para-
mount importance to obtain reproducible results and allow
objective comparison to other DR CAD systems.
The CAD system achieved a performance of the area Az
under the ROC curve of 0.876, similar to the performance
obtained by the experts. At a specificity of 50%, the CAD
system obtained a sensitivity of 92.2%, comparable to the
performance of the experts. With this setting, the system offers
a valuable opportunity to reduce the manual burden of grading
with a workload reduction of 50%. Among the 51 images
misclassified by the system as normal, no images with high risk
of macular edema were missed. Only three images with high
retinopathy grade were wrongly classified, according to the
reference standard. However, the experts did not agree on the
grade of those images, one even classifying two of them as
having grade 0. CAD offers retinopathy screening programs a
fast solution to screen diabetes population. The average time to
process one examination is less than 3 minutes for nonmulti-
threaded software written in C running on a 2.66-Ghz quad
processor (Core 2; Intel, Mountain View, CA).
The performance of the CAD system on the differential
retinopathy grading was also comparable to that of the human
observers. For the CAD system and for the experts, the differ-
entiation between normal images and images with retinopathy
grade 1 according to the reference standard was the most
difficult task. In fact, in some screening systems, patients with
up to only five microaneurysms are not even referred. When a
distinction between referable (retinopathy grades 2 and 3) and
nonreferable (retinopathy grade 0 and 1) images was per-
formed on the Messidor database, areas Az under the ROC
curve of 0.91, 0.94, and 0.92 were obtained by the CAD system
and the experts A and B, respectively, with sensitivity of 94.4%,
98.2%, and 97.6% at a specificity of 50%.
The observer study showed that there was low agreement
on the grading of retinal images, even when adhering to a strict
protocol such as the one proposed in Table 1. These results
suggest that human grading is subjective, depending on the
reader and his or her experience. An automatic method that
could assess automatically the retinopathy grade might be of
value for reducing the high interobserver variability of grading.
It should be emphasized that the performance of a CAD system
cannot exceed the human performance due to the lack of an
objective gold standard. The system was trained using the
annotations made by specific observers, and its performance
therefore depends on the observer’s opinion.
The CAD has performance level on the Messidor database
similar to those reported in our previous studies using different
databases.5,15 In these studies, the system achieved an area Az
under the ROC curve of 0.84 and 0.88, with databases of
10,000 and 15,000 examinations, respectively. These compa-
rable performance levels highlight the reliability of the pro-
posed system in the face of data changes, such as screening
protocol and number of images per examination and quality.
However, it should be noted that the performance may dete-
riorate in images taken from the screening setting, as they
present lower quality than images acquired from clinical set-
tings. In addition, it is reasonable to assume that a higher
performance can be obtained in images with a higher resolu-
tion. Measuring the CAD performance with respect to the
image resolution, areas under the ROC curve of 0.927, 0.914,
and 0.935 were obtained for resolutions of 1440  960,
2240  1488, and 2304  1536, respectively. We randomly
selected 120 images (60 normal, 30 images with retinopathy
grade 2, and 30 images with retinopathy grade 3) for each
image resolution, to obtain a similar image distribution. The
TABLE 4. Confusion Matrices, Weighted  Agreement, and 95% CI
for Risk of Macular Edema between the Reference Standard
and the Experts
Expert A Expert B
Grade 0 Grade 1 Grade 2 Grade 0 Grade 1 Grade 2
Grade 0 810 117 47 899 34 41
Grade 1 4 42 29 29 31 15
Grade 2 5 5 141 29 7 115
  0.667   0.657
95% CI  0.623–0.710 95% CI  0.605–0.709
The columns indicate the experts’ performance; the rows indicate
the reference standard.
TABLE 5. Confusion Matrices, Weighted  Agreement, and 95% CI
for Retinopathy Grade between the Experts
Grade 0 Grade 1 Grade 2 Grade 3
Grade 0 599 151 76 1
Grade 1 0 7 12 3
Grade 2 2 24 110 26
Grade 3 3 0 49 137
  0.694
95% CI  0.664–0.725
The columns indicate the performance of Expert B; the rows
indicate the performance of Expert A.
TABLE 3. Confusion Matrices, Weighted  Agreement, and 95% CI for Retinopathy Grade between the
Reference Standard and the Experts
Expert A Expert B
Grade 0 Grade 1 Grade 2 Grade 3 Grade 0 Grade 1 Grade 2 Grade 3
Grade 0 502 39 5 0 544 0 0 2
Grade 1 72 69 11 1 146 3 3 1
Grade 2 28 64 147 8 117 4 105 21
Grade 3 2 10 84 158 20 15 54 165
  0.755   0.637
95% CI  0.733–0.780 95% CI  0.604–0.670
The columns indicate the observer performance; the rows indicate the reference standard.
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performance was not significantly different for images with
different resolutions. Therefore, we cannot state that the CAD
system performed better in images with higher resolution.
However, more experiments should be performed to obtain a
reliable measurement.
This study has limitations that need to be considered. First,
the performance of the CAD is only compared to a single
reading by two experts. Annotations from more specialists and
the establishment of a gold standard are needed to perform a
meaningful evaluation of the CAD’s performance. Second, the
CAD system does not detect isolated large hemorrhages. This
may be the explanation for the slightly lower performance
compared to expert A. The system could therefore be im-
proved by adding a dedicated component for the identification
of large hemorrhages. It should be noted that the proposed
CAD system focused only in the detection of the earliest signs
of DR, without a differentiation between different retinopathy
grades. In future work, our research will be oriented to identify
lesions that appear in more advance stages of DR, such as
neovascularization, and to provide an automatic analysis of the
retinopathy grade and the risk of macular edema.
Together with previous studies,5,15 this study confirms that
the proposed CAD system reaches similar results in different
databases and performance comparable to human observers. In
addition, it has been shown that automated grading methods
for DR screening is a cost-effective alternative to manual grad-
ing.8 In the view of these facts, the proposed CAD system is
likely to be considered for screening practice, provided the
remaining procedural, safety, and legal issues are resolved.
In conclusion, this study showed the performance of a
comprehensive DR screening system on an independent, pub-
licly available database. The performance of the system on this
dataset is comparable to that of human experts and in accor-
dance with the results obtained in previous studies. The system
offers retinopathy screening programs a fast solution to reduce
the burden of screening diabetes population while maintaining
a high sensitivity.
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